General Information
Version
1.1
Revision date
2021-12-08
Product name
Prascend tablets (pergolide mesylate) Tablets, 1 mg
Product Synonyms
Prascend® (pergolide tablets) 1 mg
1.2.1 Relevant identified uses
Pharmaceutical Dopamine receptor agonist for oral use in horses only
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- nary use only, Refer to the product insert for complete instruc- tions on usage Federal law restricts this drug to use by or on the order of a licensed veterinarian
supplier name
Boehringer Ingelheim AH USA
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim AH USA
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
Hazard Codes
Hazard statements (CLP)
H362
Hazard statements
Code
Statements
H362
May cause harm to breast-fed children
Section 2
SECTION 2: Hazards identification
Hazard statements
H362 May cause harm to breast-fed children.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust or mist. P263 Avoid contact during pregnancy/ while nursing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
1910.1200) Effects on or via lactation
